TTG-103

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameTTG-103
Drug Alias NameTTG-103
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Voltage-gated potassium channel subunit Kv1.3
TargetsVoltage-gated potassium channel subunit Kv1.3
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTetragenetics
China Registration ClassN/A

Develop Information

Active CompaniesTetragenetics
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A